Annovera was launched in 2018 in USA. Well
established product in Pharma. TherapeuticsMD
total revenue as stated was small. Total combined
for first 9 months 2022 was $68m. That’s all the
products.
- Forums
- ASX - By Stock
- MYX
- Ann: MYX signs license agreement for women's health products
Ann: MYX signs license agreement for women's health products, page-104
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.37 |
Change
-0.035(0.80%) |
Mkt cap ! $369.2M |
Open | High | Low | Value | Volume |
$4.42 | $4.45 | $4.23 | $604.9K | 139.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 700 | $4.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.37 | 115 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1446 | 4.360 |
8 | 1512 | 4.350 |
7 | 2411 | 4.340 |
6 | 3090 | 4.330 |
5 | 4374 | 4.320 |
Price($) | Vol. | No. |
---|---|---|
4.370 | 13 | 1 |
4.380 | 511 | 4 |
4.390 | 1038 | 7 |
4.400 | 564 | 3 |
4.410 | 1167 | 4 |
Last trade - 14.22pm 15/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online